O2-5-6 - Neutrophil to lymphocyte ratio (NLR) as an early marker for outcome in patients treated with nivolumab in advanced NSCLC
- Resource Type
- Article
- Source
- In
Annals of Oncology October 2017 28 Supplement 9:ix85-ix85 - Subject
- Language
- ISSN
- 0923-7534